CLLS
Cellectis S.A.
NASDAQ · Healthcare · Biotechnology · FR
$3.24
−2.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.94x
- Price / sales
- 5.77x
- Price / cash flow
- -7.79x
Enterprise value
- Enterprise value
- $244.0M
- EV / sales
- 4.31x
- EV / EBITDA
- -4.40x
- EV / EBIT
- -3.94x
- Market cap
- $326.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026